The global medical simulation market reflects this momentum, projected to grow from $ 1.65B in 2024 to $ 4.17B by 2030.”
EXPERT INSIGHTS
virtual prototyping under varied physiological conditions.
The global medical simulation market reflects this momentum, projected to grow from $ 1.65B in 2024 to $ 4.17B by 2030. As multimodal AI systems like the AI-Driven Digital Organism( AIDO) emerge, capable of simulating biology from molecules to entire organisms, biocompatibility is evolving from a reactive checkpoint into a proactive design principle. This transformation empowers developers to engineer materials that actively communicate with biological systems, enhancing safety, accelerating innovation, and aligning with both regulatory and ethical standards.
Despite the promising advances enabled by AI and simulation in medical device development, key hurdles persist such as limited data resources, where the absence of extensive, high-quality datasets on material behavior and biological interactions hampers model precision. Strengthening collaboration across institutions is vital to build, harmonize, and share robust data collections. To gain trust and regulatory approval, AI and simulation models must undergo thorough validation against empirical
The global medical simulation market reflects this momentum, projected to grow from $ 1.65B in 2024 to $ 4.17B by 2030.”
data, which proves to be challenging. Techniques like molecular dynamics simulations require significant computing power.
Optimized algorithms and scalable access to high-performance computing are critical to manage these demands. Merging AI with simulation provides deeper insights into biological responses, but it also calls for innovative approaches to unify data across different scales and formats, making integration needs complex
These challenges emphasize the need for collaboration across disciplines— data scientists, engineers, clinicians, and regulators. As AI advances, biocompatibility is becoming a proactive design strategy, with materials engineered to interact intelligently with biology. Yet, human expertise remains vital to interpret AI insights, validate predictions, uphold ethics, and make context-driven decisions. This human-AI partnership ensures innovation is safe, accountable, and aligned with realworld needs, shaping a future where materials are not just tested, but truly understood.
Data-Led Material Behavior Analysis: Ethical Compliance by Design
40
BioVoiceNews | September 2025